Volume 112, Issue 1 p. 40-44
Clinical articles

Oral misoprostol as an alternative to surgical management for incomplete abortion in Ghana

Joseph Taylor

Joseph Taylor

Koforidua Regional Hospital, Koforidua, Ghana

Search for more papers by this author
Ayisha Diop

Ayisha Diop

Gynuity Health Projects, New York, USA

Search for more papers by this author
Jennifer Blum

Corresponding Author

Jennifer Blum

Gynuity Health Projects, New York, USA

Corresponding author. Gynuity Health Projects, 15 East 26th Street, New York, NY 10010, USA. Tel.: + 1 212 448 1230; fax: + 1 212 448 1260.Search for more papers by this author
Obed Dolo

Obed Dolo

Koforidua Regional Hospital, Koforidua, Ghana

Search for more papers by this author
Beverly Winikoff

Beverly Winikoff

Gynuity Health Projects, New York, USA

Search for more papers by this author
First published: 30 November 2010
Citations: 22

Abstract

Objective

To investigate whether 600-μg oral misoprostol is an effective alternative to manual vacuum aspiration (MVA) for the treatment of incomplete abortion.

Methods

From June 16, 2004, to July 20, 2005, 230 women of reproductive age presenting with incomplete abortion were randomized in an open-label trial to either 600-μg oral misoprostol or MVA for the treatment of incomplete abortion.

Results

Regardless of the assigned method, more than 98% of participants experienced complete uterine evacuation following initial treatment. Efficacy, acceptability, and satisfaction ratings were similar and high for both methods.

Conclusion

600-μg oral misoprostol is a safe, effective, and acceptable alternative to MVA for the treatment of incomplete abortion.